Amplia Therapeutics Ltd Cash Flow Conversion Efficiency

Latest as of March 2026: -0.028x

Amplia Therapeutics Ltd cash flow conversion efficiency. Based on the latest financial reports, Amplia Therapeutics Ltd (ATX) has a cash flow conversion efficiency ratio of -0.028x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.09 Million ≈ $-768.53K USD) by net assets (AU$39.47 Million ≈ $27.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Amplia Therapeutics Ltd (2010–2026)

Cash flow conversion efficiency of Amplia Therapeutics Ltd from 2010 to 2026. This chart illustrates how Amplia Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ATX live share price for real-time trading data and today's change.

Amplia Therapeutics Ltd Cash Flow Conversion Ratio Explained

Amplia Therapeutics Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Amplia Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Amplia Therapeutics Ltd ranked by their cash flow conversion efficiency. Also see Amplia Therapeutics Ltd stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Ozderici Gayrimenkul Yatirim Ortakligi AS IS:OZGYO	0.006x
Jin Yang Pharmaceutical Co. Ltd KQ:007370	0.050x
Pre-Built Public Company Limited BK:PREB	0.106x
Emami Realty Limited NSE:EMAMIREAL	0.400x
InBioGen Co Ltd KO:101140	-0.010x
Subur Tiasa Holdings Bhd KLSE:6904	0.003x
Kekrops S.A. AT:KEKR	-0.005x
IMS SA WAR:IMS	0.157x

Annual Cash Flow Conversion Efficiency for Amplia Therapeutics Ltd (2010–2026)

The table below shows the annual cash flow conversion efficiency of Amplia Therapeutics Ltd from 2010 to 2026. Review ATX financial flexibility index to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	AU$39.47 Million ≈ $27.93 Million	AU$-8.73 Million ≈ $-6.18 Million	-0.221x	+32.44%
2025-03-31	AU$21.02 Million ≈ $14.88 Million	AU$-6.89 Million ≈ $-4.87 Million	-0.328x	+27.06%
2024-03-31	AU$11.42 Million ≈ $8.08 Million	AU$-5.13 Million ≈ $-3.63 Million	-0.449x	-34.42%
2023-03-31	AU$15.84 Million ≈ $11.20 Million	AU$-5.29 Million ≈ $-3.74 Million	-0.334x	-65.79%
2022-03-31	AU$21.85 Million ≈ $15.46 Million	AU$-4.40 Million ≈ $-3.11 Million	-0.201x	+28.56%
2021-03-31	AU$10.34 Million ≈ $7.32 Million	AU$-2.92 Million ≈ $-2.06 Million	-0.282x	-16.24%
2020-03-31	AU$8.61 Million ≈ $6.09 Million	AU$-2.09 Million ≈ $-1.48 Million	-0.243x	-112.92%
2019-03-31	AU$8.66 Million ≈ $6.13 Million	AU$-987.35K ≈ $-698.61K	-0.114x	+92.41%
2018-03-31	AU$2.36 Million ≈ $1.67 Million	AU$-3.55 Million ≈ $-2.51 Million	-1.501x	-61.48%
2017-03-31	AU$6.63 Million ≈ $4.69 Million	AU$-6.16 Million ≈ $-4.36 Million	-0.930x	+21.06%
2016-03-31	AU$4.00 Million ≈ $2.83 Million	AU$-4.71 Million ≈ $-3.34 Million	-1.178x	-44.06%
2015-03-31	AU$4.87 Million ≈ $3.44 Million	AU$-3.98 Million ≈ $-2.81 Million	-0.817x	-397.85%
2014-03-31	AU$9.77 Million ≈ $6.91 Million	AU$-1.60 Million ≈ $-1.14 Million	-0.164x	-5.13%
2013-03-31	AU$11.23 Million ≈ $7.95 Million	AU$-1.75 Million ≈ $-1.24 Million	-0.156x	+60.77%
2012-03-31	AU$3.19 Million ≈ $2.26 Million	AU$-1.27 Million ≈ $-899.95K	-0.398x	-50.85%
2011-03-31	AU$6.07 Million ≈ $4.30 Million	AU$-1.60 Million ≈ $-1.13 Million	-0.264x	+22.54%
2010-03-31	AU$5.98 Million ≈ $4.23 Million	AU$-2.04 Million ≈ $-1.44 Million	-0.341x	--

About Amplia Therapeutics Ltd

AU:ATX Australia Biotechnology

Market Cap

$32.69 Million

AU$46.20 Million AUD

Market Cap Rank

#23235 Global

#857 in Australia

Share Price

AU$0.09

Change (1 day)

+1.12%

52-Week Range

AU$0.08 - AU$0.27

All Time High

AU$16.20